Home›Companies›Biotech & Pharma›Primrose Bio

Primrose Bio, Inc.

Updated Oct 27, 2026·Latest SEC filing Jul 17, 2024·Suggest an edit

About Primrose Bio

Primrose Bio is a private company based in San Diego, California, incorporated in 2023 in Delaware. It has reported $14,999,999 raised in one offering on Form D since July 2024. Its chief executive is Helge Zieler.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 17, 2024Jul 17, 2024$14,999,999of $22.9M target2$7.4MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Primrose Bio's Form D filed Jul 17, 2024.

HZ
Helge Zieler
Chief Executive Officer and director
JM
J. Mitchell
Director
MR
WK
Wes Kaupinen
Director

Sources

  1. SECPrimrose Bio, Inc. filing history